Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

TSE:L

Loblaw Companies Ltd (L.TO)

60.53
-0.44 (0.72%)
as of Aug 21, 2026, 8:00:00 pm Market Open.
322 watching
0
Investor Insights
star iconAug 23, 2026, 12:00 am

This summary was created by AI, based on 11 opinions in the last 12 months.

Loblaw Companies Ltd, a leading food and drug retailer in Canada, has experienced significant growth, especially following its acquisition of Shoppers Drug Mart. Experts note its strong performance amid food inflation, and the success of its No Frills discount brand has drawn positive attention. However, concerns about overvaluation are prevalent, with many analysts watching for signs of sustainable growth, especially with increasing competition from Walmart and Costco. While some view the company as a solid defensive investment, others are cautious, indicating that current valuations appear stretched compared to historical standards. Analysts provide mixed views on its future performance, recommending investors consider alternatives in the retail space.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Overvalued
review icon
Similar
ATD
COMMENT

A low yielder, but have increased the dividend recently. They’ve done a good job of putting food retailing and Shoppers Drug stores together. It is a slow business. Typically, food retailers do well when there is food inflation.

PAST TOP PICK

(A Top Pick May 18/16. Up 14%.) She likes the food retail and the drug retail. They have great locations. A lot of their Shoppers outlets are offering fresh food, which is a good concept in the urban centres.

TOP PICK

The program was interupted by a news flash from Washington, and wasn't inished. Top Picks are not talked about today.

COMMENT

This will probably be another distribution hub for marijuana at some time. He suspects it would have a very small impact on the stock. Thinks there are better opportunities elsewhere.

DON'T BUY

A consumer staples name which is in the defensive space. He is completely underweight the area. It has just moved up and down over the past 12 months or so, and has really been quite sideways. Shares are trading at 16X forward earnings with a 10% growth rate, trading in line with historical valuations. With food deflation and lower prices in a very highly competitive industry, this is a name he would not be rushing out to buy. It could face a potential slowdown in sales growth. Shoppers is working well for them, but not enough to push the shares higher in an environment where cyclical stocks are doing well.

WAIT

Historically this has been a summer stock. Normally it starts to do well at approximately the middle of June right through until the end of September. It’s in a trading range right now and not doing much of anything. If you see this moving above its trading range by the middle of June, that is going to be the set up for the next seasonal trade, which will take you into September. Dividend yield of 1.5%.

COMMENT

An interesting name. Recently they have kind of listened to the consumer, and started to be more competitive on pricing. Being in the consumer staples space is a reason why he doesn’t like this as a name in the portfolio. However, compared to some of the other food retailers, he likes it, especially with its diversification into Shoppers Drug Mart, which is a much higher margin business.

BUY

Has never been a fan of the food industry. However, if you want a relatively safe stock and a company that is doing reasonably well right now, this is a good place to put your money.

COMMENT

A consumer staple on the Canadian side. Seasonally, they are typically better to own in the summer. Not for the “buy and hold” investor, this is a stock for the trader, Buy at $60 and Sell at around $70.

COMMENT

He owns this through George Weston (WN-T) which also has the bakery business in the US. The stock has pulled back to the $67-$68 price range. You are seeing a reflection of the environment that grocery stores are finding themselves in. A very, very competitive environment. Consumers have been going more and more into lower priced stores. There is an inability for them to pass on price inflation. For the time being, we may see some margin compression. Over the last number of years the company has successfully put in a new SAP system, revamped their supply chain and did some management restructuring. He would look at this as a premier player in the Canadian grocery market.

PAST TOP PICK

(A Top Pick Dec 3/15. Up 7.24%.) He took profits on this a while ago. Being in the consumer staples space, he doesn’t pay attention to this particular area. He does like this stock.

COMMENT

Competition is fierce, but in terms of square footage growth, it has moderated from prior years. Loblaw owns Shopper Drugs as well, and she likes the drug retail. Also they both have the best locations. The company has gone through a period where they introduced new IT systems, refurbished larger stores, and are seeing the benefit of that flow through now.

COMMENT

Has a very small position in this. A well-managed company. The Shoppers acquisition is going along very well. Typically, these food retail companies do very well when inflation is going up, so if we get a rise in inflation in the next couple of years, it will be good for them. However, money is coming out of consumer stocks and going into the more commodity oriented stocks.

BUY

He owns both L-T and WN-T. They have done a great job of being more efficient and integrating Shoppers. They generate a healthy amount of cash. It is not dirt cheap, but you can get it at an attractive price. Buy it and leave it.

COMMENT

Long-term hold? He is not enthused about the industry. It had some good market moves when people were looking for safe places, but the competition is fierce. Everybody is getting into this field. It is such a thin margin business and so competitive that he would rather go elsewhere.

Showing 151 to 165 of 707 entries